Equity Overview
Price & Market Data
Price: $0.96
Daily Change: -$0.0125 / 1.30%
Range: $0.96 - $1.02
Market Cap: $37,952,832
Volume: 2,196
Performance Metrics
1 Week: 4.98%
1 Month: -28.75%
3 Months: -63.04%
6 Months: -64.51%
1 Year: -77.91%
YTD: -67.76%
Company Details
Employees: 209
Sector: Health technology
Industry: Medical specialties
Country: United States
Details
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.